This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Nien-Yi Chen: Innovator in Biotechnology
Introduction
Nien-Yi Chen is a prominent inventor based in Sindinn, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of neutralizing antibodies against enterovirus 71.
Latest Patents
Nien-Yi Chen holds a patent for "Recombinant enterovirus 71 neutralizing antibodies and applications thereof." This patent includes an antibody against enterovirus 71, comprising specific amino acid sequences or functionally active homologues. The patent outlines methods for obtaining the antibody, including selecting a yeast expressing the antibody from a library, culturing the yeast, and recovering the antibody from the culture. Additionally, it describes a process for producing the antibody using host cells that are transformed or transfected to express the antibody against enterovirus 71. The patent also covers pharmaceutical compositions that include the antibody and a pharmaceutically acceptable carrier or diluent.
Career Highlights
Nien-Yi Chen is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in the field. His work has led to innovative solutions for combating viral infections, showcasing his expertise and dedication to biotechnology.
Collaborations
Nien-Yi Chen has collaborated with notable colleagues, including Tse-Wen Chang and Lee-Hwa Lo, contributing to various projects that enhance the understanding and treatment of viral diseases.
Conclusion
Nien-Yi Chen's contributions to biotechnology, particularly through his patent on enterovirus 71 neutralizing antibodies, highlight his role as an innovator in the field. His work continues to impact the development of effective treatments for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
